HRMY Harmony Biosciences Holdings
P/E
15.02
Forward P/E
11.42
Price/Sales
2.399
Beta
0.969
Div Yield
--
Market Cap
--
Company Analysis
Latest News
Harmony Biosciences Reaffirmed at Mizuho, Trial Review Supports Wakix Patent
Mizuho reiterated its Outperform rating and $50.00 price target for Harmony Biosciences. The firm issued the update after reviewing trial transcripts regarding...
🟢 HRMY is trading 4.5% up today as it tests resistance amid healthcare sector rotation
HRMY is trading at $38.66 (up 4.5%) as the stock maintains strong bullish momentum and technical strength. • The stock is currently testing a key resistance...